Thomas E. (Ted) Keim, Jr.

Ted Keim

Ted Keim's practice focuses on mergers and acquisitions, investment and venture capital transactions, private equity, corporate reorganizations and restructurings, and complex joint venture/company representation matters.  Ted's clients include a broad range of public and privately held companies, both in the United States and globally, across a wide spectrum of industries, including healthcare and life sciences/medical devices, food and beverage, financial and technology services, industrials, automotive, aerospace and defense, retail, and hospitality.


Representative Matters

  • Represented EMZ portfolio company FotoFinder Systems, Inc., a Germany-based global leader in skin imaging solutions, in connection with its acquisition of DermLite LLC, a U.S.-based handheld dermoscopy device company
  • Representing a European private equity purchaser in bolt-on acquisition of a U.S. medical device business from private equity seller
  • Representing a global consumer products corporation in connection with the divesture of its controlling stake in an Indian public company subsidiary
  • Represented a global hospitality company in various brand affiliation/loyalty agreements
  • Represented a low-carbon cement and concrete technology company in various corporate and commercial matters
  • Represented a European/global consumer and personal care products company in the carve-out acquisition of a sealings and coatings business
  • Represented a private equity-owned sensor and technology business in the sale to a private equity-backed strategic acquiror
  • Represented the purchaser of a flooring products company in the acquisition from a private equity seller
  • Represented a private investor group in its acquisition of a controlling interest in a high-profile sports/media-related property and advised on various corporate and commercial matters
  • Represented a medical technology supplier in connection with its acquisition of a digital health provider of ambulatory cardiac monitoring technologies, and transaction-related Delaware Chancery Court litigation
  • Represented a medical technology supplier in connection with its acquisition of a medical device company
  • Represented a French evergreen investment company in connection with its inaugural U.S. preferred equity investment in a global healthcare firm
  • Represented a multi-stage venture capital fund in its Series C-1 growth investment in a manufacturer of carbon black using natural gas feedstock
  • Represented a privately held U.S. biotechnology company in connection with an investment and share repurchase/tender offer transaction involving more than $500 million in contemplated transaction value and settlement of minority shareholder litigation
  • Represented a medical technology supplier in its acquisition of a Mexico City-based medical device software connectivity developer
  • Represented a global logistics company in connection with the structuring and formation of a joint venture in India
  • Represented a medical device supplier in its acquisition of a medical device integration platform company
  • Represented numerous specialty lenders in connection with equity-related matters regarding various lending and restructuring transactions across multiple industries, including healthcare, home health and addiction treatment, telecommunications, restaurants and hospitality, and home repair and automotive services
  • Represented a research company in an IP evaluation and transfer agreement with a manufacturer, distributor, and solutions provider
  • Represented a Chicago-based family office in connection with the acquisition of a dedicated financial, tax, and consulting services firm and related management transition matters
  • Represented a U.S.-based dental medical device manufacturer in the acquisition of 510(k) FDA approval
  • Represented a wax manufacturer in the sale of a business line to a manufacturing and supply company
  • Represented a healthcare company in its acquisition of an India-based generics injectables pharmaceutical company
  • Represented an investment management firm in the sale of its investment platform to a commercial real estate firm and related portfolio-winddown matters
  • Represented a U.S. commercial airline in a debt and equity investment in an early-stage travel distribution platform and related governance matters
  • Represented a chemical company in its sale to a major American adhesives manufacturing company
  • Represented a pharmaceutical company in its purchase of a pre-filled syringe business
  • Represented a precision motor, motion subsystem, and related electromechanical component company in its acquisition of a manufacturing company specializing in innovative engine/transmission pumps and powder metal components in the global automotive industry from a private equity firm
  • Represented a sensor technology company in its sale to a technology distributor
  • Represented a biopharmaceutical company in the acquisition of an oncology pharmaceutical product portfolio from a pharmaceutical company
  • Represented a U.S. supermarket chain in the sale of its Canadian grocery operations
  • Represented a global fertilizer company in its acquisition of a specialty fertilizer business from an agricultural company
  • Represented a wax manufacturer in various acquisition and disposition transactions
  • Represented a health supplement company in its acquisition of a supplement manufacturing company
  • Represented a multinational conglomerate corporation in various bioenergy/ethanol plant acquisitions
  • Represented a family business and partner's interests in the sale of a global information and insights company to private equity firms
  • Represented a high-pressure die casting aluminum auto parts manufacturer in its sale to a global automotive parts manufacturing company
  • Represented a U.S. drugstore chain in its acquisition of an infusion pharmaceutical company
  • Represented an American industrial holding company and the owner of a private family business in the sale of an industrial holding company to an American multinational conglomerate holding company
  • Represented a pharmaceutical company in its sale to a global biopharma company and, prior thereto, various acquisition, disposition, and fundraising transactions




  • J.D. University of Chicago Law School 1993
  • M. Phil. University of Cambridge 1990
  • B.A. summa cum laude Yale University 1989

Bar Admissions

  • Illinois

Court Admissions

  • U.S. District Court for the District of Illinois

Professional Memberships and Activities

  • Member, Advisory Board, Museum of Contemporary Photography, Columbia College
  • Alumni admissions representative, Philips Academy
  • Former member, Auxiliary Board, Art Institute of Chicago


  • Chambers USA, Corporate/M&A (Band 3), 2009 – 2023
  • ILFR 1000, Notable Practitioner, 2020 – 2022